Sanjiv Patel
Chief Executive Officer bei RELAY THERAPEUTICS, INC.
Vermögen: 18 Mio $ am 31.03.2024
Profil
Derzeit bekleidet Sanjiv K. Patel die Position des President, Chief Executive Officer & Director bei Relay Therapeutics, Inc. Er ist außerdem Mitglied des Royal College of Surgeons of England. Dr. Patel hatte zuvor die Position des Chief Strategy Officer bei Allergan Ltd. (Irland). Er erhielt einen Doktortitel von der University of London, einen MBA von INSEAD und einen Hochschulabschluss von der University of Cambridge.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RELAY THERAPEUTICS, INC.
1,62% | 16.01.2024 | 2 125 925 ( 1,62% ) | 18 Mio $ | 31.03.2024 |
Aktive Positionen von Sanjiv Patel
| Unternehmen | Position | Beginn |
|---|---|---|
| RELAY THERAPEUTICS, INC. | Chief Executive Officer | 01.03.2017 |
| ARYA SCIENCES ACQUISITION CORP V | Director/Board Member | 01.07.2021 |
| The Royal College of Surgeons of England | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Sanjiv Patel
| Unternehmen | Position | Ende |
|---|---|---|
| PROTHENA CORPORATION PLC | Director/Board Member | 01.07.2023 |
| ALLERGAN PLC | Corporate Officer/Principal | 01.03.2017 |
| ALLERGAN, INC. | Corporate Officer/Principal | 01.01.2017 |
Ausbildung von Sanjiv Patel
| University of Cambridge | Graduate Degree |
| University of London | Doctorate Degree |
| INSEAD | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| RELAY THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
ARYA Sciences Acquisition Corp. V
 ARYA Sciences Acquisition Corp. V Financial ConglomeratesFinance Arya Sciences Acquisition Corp. V is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Adam Stones, Joseph Eric Edelman, Michael R. Altman, and Konstantin Poukalov on February 22, 2021 and is headquartered in New York, NY. | Finance |
